Chembond Chemicals Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Chembond Chemicals (NSE: CHEMBOND) Q4 FY26 results are scheduled for May 15, 2026. Trading at Rs 380 as of April 2026 — down -38% from its 52-week high of Rs 620 — the stock has been on investors’ watchlist ahead of what could be a pivotal quarterly result. This article covers the confirmed results date, analyst consensus estimates, five performance factors, five risks, analyst ratings, and share price outlook for Chembond Chemicals.

Q4 (January-March 2026) is the year’s final quarter, bringing full-year FY26 results, management’s FY27 guidance, and the final dividend recommendation — all from a single board meeting on May 15, 2026.

Get free investment predictions from SEBI-registered analysts on Univest.

Chembond Chemicals Q4 Results 2026 Date

Chembond Chemicals Q4 FY26 results date is May 15, 2026.

Why Q4 FY26 Matters

Q4 FY26 is the final quarter of FY2025-26. Chembond Chemicals’s board on May 15, 2026 will approve the full-year FY26 results, consider a final dividend recommendation, and provide the first formal commentary on FY27 business outlook — making this the single most important results event of the year.

Chembond Chemicals Q4 FY26 Earnings Estimates

Access premium research on Univest.

Screen Chembond Chemicals live on the Univest Screener. Download the Univest iOS App or Univest Android App for real-time Q4 result alerts.

5 Key Factors Driving Chembond Chemicals Q4 FY26 Performance

1. Water Treatment Chemicals Sector Demand Trends

Chembond Chemicals’s core Water Treatment Chemicals business is tracking the broader sector recovery in Q4 FY26. +10% volume YoY trajectory is supported by seasonal demand patterns and end-market growth.

2. Q4 Peak Season Dynamics

Q4 (January-March) is typically a seasonally stronger quarter for most sectors as year-end procurement, construction activity, and consumer buying peak before the monsoon transition.

3. Operating Leverage at Scale

Revenue growth above fixed cost base growth translates to EBITDA margin improvement as the business scales. Q4 volume improvement is the primary operating leverage driver.

4. Management Guidance for FY27

Q4 FY26 results will include management’s first formal commentary on FY27 revenue and margin outlook, which will set the investment narrative for the next 12 months.

5. Balance Sheet and Debt Management

Cash flow generation in Q4 (typically the strongest quarter) supports debt reduction or reinvestment in capacity expansion for FY27.

5 Risks to Watch in Chembond Chemicals Q4 FY26

Risk 1: Water Treatment Chemicals Sector Risk

Sector headwinds including input cost pressure, demand cyclicality, and competition could impact Q4 performance.

Risk 2: Revenue Concentration

Customer or geographic concentration creates variance risk.

Risk 3: Regulatory Environment

Policy and regulatory changes in the sector can create compliance or revenue risks.

Risk 4: Working Capital Management

Efficient working capital management determines free cash flow quality in Q4.

Risk 5: Macroeconomic Sensitivity

Global and domestic macroeconomic conditions affect end-market demand.

Chembond Chemicals Share Price and Analyst Ratings

Conclusion

Chembond Chemicals Q4 FY26 results on May 15, 2026 will reflect Water Treatment Chemicals sector performance in the January-March 2026 quarter. Revenue above Rs 185 Cr with EBITDA 12% would constitute a beat. The +10% volume YoY trajectory and management FY27 guidance are the primary catalysts for re-rating. At Rs 380 — down -38% from its 52-week high of Rs 620 — the stock offers a more reasonable entry point than earlier in the year.

Disclaimer: Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. All financial data and analyst estimates are sourced from publicly available information including NSE/BSE filings. Verify all numbers before investing. Consult a SEBI-registered advisor before making investment decisions.

For more Q4 FY26 results previews, visit Univest Blogs.

Frequently Asked Questions

Q: When is Chembond Chemicals Q4 results 2026 date?

Chembond Chemicals Q4 FY26 results date is May 15, 2026. The board of directors will approve the FY26 quarterly and full-year results and consider recommending a final dividend to FY26 shareholders.

Q: What is Chembond Chemicals Q4 FY26 revenue estimate?

Analyst consensus estimate for Chembond Chemicals Q4 FY26 revenue is Rs 185 Cr. Q3 FY26 actual revenue was Rs 168 Cr. Actual Q4 results may differ based on operating conditions.

Q: What is Chembond Chemicals Q4 FY26 PAT estimate?

Analyst consensus estimate for Chembond Chemicals Q4 FY26 net profit (PAT) is Rs 18 Cr. Q3 FY26 actual PAT was Rs 15 Cr.

Q: Will Chembond Chemicals declare a dividend in Q4 FY26?

Chembond Chemicals is expected to declare Rs 1 for FY26, subject to board approval on May 15, 2026 and shareholder approval at the AGM.

Q: What is Chembond Chemicals’s current share price?

Chembond Chemicals is trading at Rs 380 as of April 2026, with a 52-week range of Rs 320 to Rs 620. The 1-year return is -38%.

Q: What were Chembond Chemicals Q3 FY26 results?

In Q3 FY26, Chembond Chemicals reported revenue of Rs 168 Cr and PAT of Rs 15 Cr. Q4 FY26 on May 15, 2026 provides the year-end comparison.

Q: When do TCS and Infosys announce Q4 results 2026?

TCS declared Q4 FY26 results on April 9, 2026. Infosys is scheduled for April 23, 2026. Both are covered on Univest Blogs.

Q: Is Chembond Chemicals a good investment ahead of Q4 results?

This article does not constitute investment advice. Chembond Chemicals trades at Rs 380 — down -38% from its peak. Consult a SEBI-registered advisor before investing.

Recent Article

BLS International Services Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

BLS E-Services Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Bliss GVS Pharma Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

BLB Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

BLACKBUCK Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook